Top

Archives of Gynecology and Obstetrics

Published in:

01-09-2013 | Gynecologic Oncology

Detection of Human Papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis

Authors: Carla Limeira Barreto, Danyelly Bruneska Gondim Martins, José Luiz de Lima Filho, Vera Magalhães

Published in: Archives of Gynecology and Obstetrics | Issue 3/2013

Abstract

Objective

To assess the detection of Human Papillomavirus (HPV) in cervical biopsies, and its association with clinical response and survival of patients with cervical cancer.

Method

The presence of HPV was determined by polymerase chain reaction (nested PCR) of material from 183 paraffin blocks containing biopsies of patients with cervical cancer. Directives of the International Federation of Gynecology and Obstetrics (FIGO) were used for the clinical staging of all cases. Survival analysis was conducted with the Kaplan–Meier method and differences between the curves were calculated by the log-rank test.

Results

Amplification was positive in 78 cases, negative in 96 cases and indeterminate in 9. The detection of HPV had no statistically significant effect on the survival of patients.

Conclusions

From amongst the variables analyzed, only HPV positivity and clinical staging influenced a complete response after completing treatment. However, clinical staging was the only factor associated with progression of the disease, with patients in the early stages presenting better overall survival rates (p < 0.001).

Agência Internacional para Pesquisa do Câncer (2008) Estatística global do câncer, Organização Mundial da Saúde. http://globocan.iarc.fr/factsheet.asp. Accessed 10 Jan 2012

Instituto Nacional de Câncer José de Alencar Gomes da Silva (2011) Estimativa 2012: Incidência de Câncer no Brasil. Ministério da Saúde. http://inca.gov.br/estimativa/2012/estimativa20122011.pdf. Accessed 10 Jan 2012

Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461–1484PubMedCrossRef

Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (2002) Papilomavírus Humano (HPV): Diagnóstico e Tratamento. http://www.febrasgo.org.br/arquivos/diretrizes/079.pdf. Accessed 16 June 2010

Hellner K, Munger K (2011) Human Papillomaviruses as therapeutic targets in human cancer. J Clin Oncol 29:1785–1794PubMedCrossRef

Ho GYF, Bierman R, Beardsley NP, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338(7):423–428PubMedCrossRef

Higgins GD, Uzelin DM, Philips GE, Davy M, Roder D, Burrell CJ (1991) Increased age and mortality associated with cervical carcinomas negative for human papillomavirus. Lancet 338(8772):910–913PubMedCrossRef

Riou G, Bourhis J, Favre M, Orth G, Jeannel D, Le Doussal V (1990) Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335(8699):1171–1174PubMedCrossRef

Eifel PJ, Berek JS, Markman M (2011) Cancer of the cervix, vagina, and vulva. In: Devita VT Jr, Lawrence TS, Rosenberg SA (eds) Cancer principles and practice of oncology. Lippincott Williams and Wilkins, Philadelphia, pp 1311–1344

10.

Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K (2007) Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers. Brit J Cancer 97(8):1058–1062PubMedCrossRef

11.

Husman AMR, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF (1995) The use of general primers GP5 and GP elongated at their 3′ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057–1062CrossRef

12.

Haws ALF, He Q, Rady PL, Zhang L, Grady J, Hughes TK et al (2004) Nested PCR with the PGMY09/11 and GP5⁺/6⁺ prime sets improves detection of HPV DNA in cervical samples. J Virol Methods 122:87–93CrossRef

13.

Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A et al (2007) Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. IJID 11:313–317PubMed

14.

Haie-Meder C, Morice P, Castiglione M (2010) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(5s):37–40CrossRef

15.

Cooke SL, Temple J, MacArthur S, Zahra MA, Tan LT, Crawford RAF et al (2011) Intra-tumor genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. B J Cancer 104:361–368CrossRef

16.

Howell-Jones R, Bailey A, Beddows S, Sargent A, Silva N, Wilson G et al (2010) Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. BJC 103:209–216PubMedCrossRef

17.

Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferency A et al (2007) Human Papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357(16):1579–1588PubMedCrossRef

18.

Huang HJ, Huang SL, Lin CY, Lin RW, Chao FY, Chen MY et al (2004) Human papillomavirus genotyping by polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 14:639–649PubMedCrossRef

19.

Prétet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B et al (2007) Human Papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 122:428–432CrossRef

20.

Huang LW, Chao SL, Hwang JL (2004) Human Papillomavirus-31-related types predict better survival in cervical carcinoma. Cancer 100(2):327–334PubMedCrossRef

21.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival for patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269PubMedCrossRef

Title: Detection of Human Papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis
Authors: Carla Limeira Barreto
Danyelly Bruneska Gondim Martins
José Luiz de Lima Filho
Vera Magalhães
Publication date: 01-09-2013
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 3/2013
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-013-2803-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Detection of Human Papillomavirus in biopsies of patients with cervical cancer, and its association with prognosis

Abstract

Objective

Method

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2013

Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A self-sampling study

Hyperemesis gravidarum: measurement of total and active ghrelin levels

Obstetric and neonatal outcomes of women with FGM I and II in San Camillo Hospital, Burkina Faso

Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes

HE4 and its evolving role in assessing tumor prognosis in gynecological and systemic malignancies

Analysis about the influence on the fetus infected with parvovirus B19 using amniotic erythropoietin and troponin-T